RAP2C expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.881000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.570200E-01
Normal-vs-Stage2
4.067400E-01
Normal-vs-Stage3
2.214200E-01
Normal-vs-Stage4
4.722400E-01
Stage1-vs-Stage2
6.105800E-01
Stage1-vs-Stage3
8.165200E-01
Stage1-vs-Stage4
2.151600E-01
Stage2-vs-Stage3
5.378400E-01
Stage2-vs-Stage4
4.130800E-01
Stage3-vs-Stage4
2.974000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.832800E-01
Normal-vs-AfricanAmerican
2.092400E-01
Normal-vs-Asian
1.010640E-01
Caucasian-vs-AfricanAmerican
8.088400E-01
Caucasian-vs-Asian
9.088600E-01
AfricanAmerican-vs-Asian
7.789800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.781400E-01
Normal-vs-Female
4.052000E-01
Male-vs-Female
5.007200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.953000E-01
Normal-vs-Age(41-60Yrs)
4.928600E-01
Normal-vs-Age(61-80Yrs)
3.503400E-01
Normal-vs-Age(81-100Yrs)
3.461800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.233400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.025600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.226400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.518500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.640400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.061800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.716800E-01
Normal-vs-Daily Drinker
3.239400E-01
Normal-vs-Weekly Drinker
3.642200E-01
Normal-vs-Occasional Drinker
1.240640E-01
Normal-vs-Social Drinker
3.805400E-01
Non Drinker-vs-Daily Drinker
4.281600E-01
Non Drinker-vs-Weekly Drinker
8.852600E-01
Non Drinker-vs-Occasional Drinker
5.192200E-01
Non Drinker-vs-Social Drinker
9.153000E-01
Daily Drinker-vs-Weekly Drinker
6.052800E-01
Daily Drinker-vs-Occasional Drinker
2.407200E-01
Daily Drinker-vs-Social Drinker
4.403000E-01
Weekly Drinker-vs-Occasional Drinker
5.277000E-01
Weekly Drinker-vs-Social Drinker
8.187400E-01
Occasional Drinker-vs-Social Drinker
6.391200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.132200E-01
Normal-vs-Grade 2
6.090800E-01
Normal-vs-Grade 3
1.575780E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.321600E-02
Grade 1-vs-Grade 3
1.116380E-02
Grade 1-vs-Grade 4
6.132200E-01
Grade 2-vs-Grade 3
4.758800E-01
Grade 2-vs-Grade 4
6.090800E-01
Grade 3-vs-Grade 4
1.575780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.430000E-01
Normal-vs-NonDiabetic
3.774400E-01
Diabetic-vs-NonDiabetic
3.943800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.458200E-01
Normal-vs-NoPancreatitis
3.729600E-01
Pancreatitis-vs-NoPancreatitis
6.531600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.655400E-01
Normal-vs-N1
4.033800E-01
N0-vs-N1
3.670200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.013600E-01
Normal-vs-TP53-NonMutant
2.821000E-01
TP53-Mutant-vs-TP53-NonMutant
2.690500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
